Cuando la curva de disociación de la hemoglobina se inclina hacia la izquierda | 30 MAR 15

¿Cuándo sospechar metahemoglobinemia?

La sospecha de metahemoglobinemia surge cuando se halla una discrepancia entre el nivel de oxihemoglobina y la saturación de oxígeno en la oximetría de pulso.
Autor/a: Bhuvnesh Aggarwal, Ruhail Kohli, Rendell Ashton, Moises Auron Fuente: Cleveland clinic journal of medicine vol. 82 • N 3. Pag 159 When the dissociation curve shifts to the left
INDICE:  1.  | 2. Referencias

1. Cortazzo JA, Lichtman AD. Methemoglobinemia: a review and recommendations for management. J Cardiothorac Vasc Anesth 2014; 28:1055–1059.
2. Margulies DR, Manookian CM. Methemoglobinemia as a cause of respiratory failure. J Trauma 2002; 52:796–797.
3. Skold A, Cosco DL, Klein R. Methemoglobinemia: pathogenesis, diagnosis, and management. South Med J 2011; 104:757–761.
4. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 2004; 83:265–273.
5. Kanji HD, Mithani S, Boucher P, Dias VC, Yarema MC. Coma, metabolic acidosis, and methemoglobinemia in a patient with acetaminophen toxicity. J Popul Ther Clin Pharmacol 2013; 20:e207–e211.
6. Kawasumi H, Tanaka E, Hoshi D, Kawaguchi Y, Yamanaka H. Methemoglobinemia induced by trimethoprimsulfamethoxazole in a patient with systemic lupus erythematosus. Intern Med 2013; 52:1741–1743.
7. Wieringa A, Bethlehem C, Hoogendoorn M, van der Maten J, van Roon EN. Very late recovery of dapsoneinduced methemoglobinemia. Clin Toxicol (Phila) 2014; 52:80–81.
8. Barclay JA, Ziemba SE, Ibrahim RB. Dapsone-induced methemoglobinemia: a primer for clinicians. Ann Pharmacother 2011; 45:1103–1115.
9. Taleb M, Ashraf Z, Valavoor S, Tinkel J. Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use. Am J Cardiovasc Drugs 2013; 13:325–330.
10. Chowdhary S, Bukoye B, Bhansali AM, et al. Risk of topical anesthetic-induced methemoglobinemia: a 10-year retrospective case-control study. JAMA Intern Med 2013; 173:771–776.
11. Larson A, Stidham T, Banerji S, Kaufman J. Seizures and methemoglobinemia in an infant after excessive EMLA application. Pediatr Emerg Care 2013; 29:377–379.
12. Schmitt C, Matulic M, Kervégant M, et al. Methaemoglobinaemia in a child treated with Emla cream: circumstances and consequences of overdose [in French]. Ann Dermatol Venereol 2012; 139:824–827.
13. Bucklin MH, Groth CM. Mortality following rasburicaseinduced methemoglobinemia. Ann Pharmacother 2013; 47:1353–1358.
14. Cheah CY, Lew TE, Seymour JF, Burbury K. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose- 6-phosphate dehydrogenase deficiency. Acta Haematol 2013; 130:254–259.
15. Druez A, Rahier JF, Hébuterne X. Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease. J Crohns Colitis 2014; 8:900–901.
16. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34:646–656.
17. Groeper K, Katcher K, Tobias JD. Anesthetic management of a patient with methemoglobinemia. South Med J 2003; 96:504–509.
18. Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem 2005; 51:434–444.
19. Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol 2013; 9:242–249.




Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2021